Evidence map›Paper›PMID 23517332›Full record

ReviewBiochemistry2013

Targeted quantitation of proteins by mass spectrometry.

Daniel C Liebler, Lisa J Zimmerman

Abstract readReview
In one paragraph

Review in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Elevated Temperature Effects on Protein Turnover Dynamics inInternational journal of molecular sciences · 2024
    Article
  18. Review
  19. Article
  20. Review

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel C LieblerDepartment of Biochemistry and Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6350, United States. daniel.liebler@vanderbilt.edu
Lisa J Zimmerman

Funding

Vanderbilt Proteome Characterization CenterU24CA159988 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LIEBLER, DANIEL C · 2011 to 2016
$13.9M
Clinical Proteomic Technology Assessment for CancerU24CA126479 · NCI · VANDERBILT UNIVERSITY · PI LIEBLER, DANIEL C · 2006 to 2010
$7.9M
Vanberbilt Biomarker Developmental LaboratoryU01CA152647 · NCI · VANDERBILT UNIVERSITY · PI LIEBLER, DANIEL C, TABB, DAVID L · 2010 to 2014
$3.1M
NCI NIH HHS U01CA152647NCI NIH HHS U24CA126479NCI NIH HHS U24 CA159988NCI NIH HHS U24CA159988
6 · The paper itself

Abstract

Quantitative measurement of proteins is one of the most fundamental analytical tasks in a biochemistry laboratory, but widely used immunochemical methods often have limited specificity and high measurement variation. In this review, we discuss applications of multiple-reaction monitoring (MRM) mass spectrometry, which allows sensitive, precise quantitative analyses of peptides and the proteins from which they are derived. Systematic development of MRM assays is permitted by databases of peptide mass spectra and sequences, software tools for analysis design and data analysis, and rapid evolution of tandem mass spectrometer technology. Key advantages of MRM assays are the ability to target specific peptide sequences, including variants and modified forms, and the capacity for multiplexing that allows analysis of dozens to hundreds of peptides. Different quantitative standardization methods provide options that balance precision, sensitivity, and assay cost. Targeted protein quantitation by MRM and related mass spectrometry methods can advance biochemistry by transforming approaches to protein measurement.

Indexed as

Mass SpectrometryPeptidesProtein Processing, Post-TranslationalProteinsProteomicsReference StandardsSensitivity and SpecificitySoftwareTandem Mass SpectrometryPeptidesProteins

Identifiers

PMID23517332
PMCPMC3674507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.